Key Takeaways Johnson & Johnson's fourth quarter sales met estimates, while net income fell short.After adjusting for ...
Minnesota Vikings QB J.J. McCarthy is a relative unknown and suffered a serious knee injury, which has led to questions ...
Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...
J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...
J.J. Watt with his wife Kealia Watt with his child (Image Credit: Getty Images) J.J. Watt is a name synonymous with NFL greatness. But beyond his legendary football career, his personal life is ...
Their latest trick has been turning up the heat on speculation the Vikings could deal rookie J.J. McCarthy in the offseason. "They are not trading J.J. McCarthy," Matthew Coller told the Star ...
The Minnesota Vikings have a big decision to make in the offseason in whether they want to re-sign Sam Darnold, who has played exceptionally well this season, or to stick with injured rookie QB J ...
J&J Buys Intra-Cellular in $14.6 Billion Deal, Delving Further Into Central Nervous System Disorders
J&J Buys Intra-Cellular in $14.6 Billion Deal, Delving Further Into Central Nervous System Disorders Johnson & Johnson will spend more than $14 billion to delve further into the treatment of ...
But could one of their options be exploring a trade for a guy in J.J. McCarthy of the Vikings, whom they had a chance to draft in 2024 but passed on? According to ESPN insider Adam Schefter ...
Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback